Novartis is the fourth ranked consumer health company in the world, with total global sales of US$4.3 billion. It has enjoyed a number of achievements in 2009/2010 including the highly successful launch of Prevacid in the US market, followed by the launch of Pantoloc Control in 14 European markets. It also successfully completed the acquisition of Alcon, which gave it a much more significant presence in eye care.

Novartis AG in Consumer Health (World) Company Profile offers detailed strategic analysis of the company's business, examining its performance in the Consumer Health industry. The report examines company shares by region and sector, product developments, market and distribution strategies, challenges from the competition and future prospects. Use it to understand opportunities and threats facing the business and the factors driving success.

Product coverage: Allergy Care, Child-Specific Consumer Health, Herbal/Traditional Products, OTC, Sports Nutrition, Vitamins and Dietary Supplements, Weight Management.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Consumer Health market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market's major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.

Click for report details: Novartis AG in Consumer Health (World) - Company Profile